Table 2.

Multivariate Cox analysis showed mutation in MLH3, NOTCH1, and TSC2 as well as signature 1 as independent prognostic markers of poor prognosis.

CovariateHR95% CIP-value
MLH3 mutation29.035.90-142.79.00003
NACA mutation0.100.00-14.30.36744
NOTCH1 mutation6.641.76-24.99.00512
NPAP1 mutation19.730.22-1.78e+03.19444
RANBP17 mutation0.100.00-14.30.36744
TSC2 mutation246.201.33-4.57e+04.03884
ZFHX4 mutation4.840.57-41.44.14996
Signature 113.871.48-130.04.0213
CovariateHR95% CIP-value
MLH3 mutation29.035.90-142.79.00003
NACA mutation0.100.00-14.30.36744
NOTCH1 mutation6.641.76-24.99.00512
NPAP1 mutation19.730.22-1.78e+03.19444
RANBP17 mutation0.100.00-14.30.36744
TSC2 mutation246.201.33-4.57e+04.03884
ZFHX4 mutation4.840.57-41.44.14996
Signature 113.871.48-130.04.0213

The significance of bold value is P value <.05.

Abbreviation: HR, hazard ratio.

Table 2.

Multivariate Cox analysis showed mutation in MLH3, NOTCH1, and TSC2 as well as signature 1 as independent prognostic markers of poor prognosis.

CovariateHR95% CIP-value
MLH3 mutation29.035.90-142.79.00003
NACA mutation0.100.00-14.30.36744
NOTCH1 mutation6.641.76-24.99.00512
NPAP1 mutation19.730.22-1.78e+03.19444
RANBP17 mutation0.100.00-14.30.36744
TSC2 mutation246.201.33-4.57e+04.03884
ZFHX4 mutation4.840.57-41.44.14996
Signature 113.871.48-130.04.0213
CovariateHR95% CIP-value
MLH3 mutation29.035.90-142.79.00003
NACA mutation0.100.00-14.30.36744
NOTCH1 mutation6.641.76-24.99.00512
NPAP1 mutation19.730.22-1.78e+03.19444
RANBP17 mutation0.100.00-14.30.36744
TSC2 mutation246.201.33-4.57e+04.03884
ZFHX4 mutation4.840.57-41.44.14996
Signature 113.871.48-130.04.0213

The significance of bold value is P value <.05.

Abbreviation: HR, hazard ratio.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close